277 related articles for article (PubMed ID: 8217588)
21. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
[TBL] [Abstract][Full Text] [Related]
22. Second malignant neoplasms following childhood Hodgkin's disease: treatment and splenectomy as risk factors.
Meadows AT; Obringer AC; Marrero O; Oberlin O; Robison L; Fossati-Bellani F; Green D; Voûte PA; Morris-Jones P; Greenberg M
Med Pediatr Oncol; 1989; 17(6):477-84. PubMed ID: 2586362
[TBL] [Abstract][Full Text] [Related]
23. Incidence of post transplant myelodysplasia/acute leukemia in non-Hodgkin's lymphoma patients compared with Hodgkin's disease patients undergoing autologous transplantation following cyclophosphamide, carmustine, and etoposide (CBV).
Wheeler C; Khurshid A; Ibrahim J; Elias A; Mauch P; Ault K; Antin J
Leuk Lymphoma; 2001 Feb; 40(5-6):499-509. PubMed ID: 11426523
[TBL] [Abstract][Full Text] [Related]
24. Second malignant neoplasms after treatment for Hodgkin's disease in childhood or adolescence.
Green DM; Hyland A; Barcos MP; Reynolds JA; Lee RJ; Hall BC; Zevon MA
J Clin Oncol; 2000 Apr; 18(7):1492-9. PubMed ID: 10735897
[TBL] [Abstract][Full Text] [Related]
25. Second malignancies after treatment of Hodgkin's disease: the influence of treatment, follow-up time, and age.
Abrahamsen JF; Andersen A; Hannisdal E; Nome O; Abrahamsen AF; Kvaløy S; Høst H
J Clin Oncol; 1993 Feb; 11(2):255-61. PubMed ID: 8426202
[TBL] [Abstract][Full Text] [Related]
26. [Late damage of curative oncologic therapy. Results of a patient sample with Hodgkin's disease and testicular tumors at the Hannover Medical School].
Bokemeyer C
Med Klin (Munich); 1996 Apr; 91 Suppl 3():60-7. PubMed ID: 8692121
[TBL] [Abstract][Full Text] [Related]
27. Leukemia following Hodgkin's disease.
Kaldor JM; Day NE; Clarke EA; Van Leeuwen FE; Henry-Amar M; Fiorentino MV; Bell J; Pedersen D; Band P; Assouline D
N Engl J Med; 1990 Jan; 322(1):7-13. PubMed ID: 2403650
[TBL] [Abstract][Full Text] [Related]
28. Second malignancies following testicular cancer, ovarian cancer and Hodgkin's disease: an international collaborative study among cancer registries.
Kaldor JM; Day NE; Band P; Choi NW; Clarke EA; Coleman MP; Hakama M; Koch M; Langmark F; Neal FE
Int J Cancer; 1987 May; 39(5):571-85. PubMed ID: 3570550
[TBL] [Abstract][Full Text] [Related]
29. Second solid tumors in patients with Hodgkin's disease cured after radiation or chemotherapy plus adjuvant low-dose radiation.
Salloum E; Doria R; Schubert W; Zelterman D; Holford T; Roberts KB; Farber LR; Kiehl RK; Cardinale J; Cooper DL
J Clin Oncol; 1996 Sep; 14(9):2435-43. PubMed ID: 8823321
[TBL] [Abstract][Full Text] [Related]
30. Thrombotic risks of staging laparotomy with splenectomy in Hodgkin's disease.
Dawson AA; Bennett B; Jones PF; Munro A
Br J Surg; 1981 Dec; 68(12):842-5. PubMed ID: 7317764
[TBL] [Abstract][Full Text] [Related]
31. Current role of radiotherapy in Hodgkin's and non-Hodgkin's lymphoma.
Shulman LN; Mauch PM
Curr Opin Oncol; 1995 Sep; 7(5):421-5. PubMed ID: 8541386
[TBL] [Abstract][Full Text] [Related]
32. Increased risk of second cancers in managing Hodgkins disease: the 20-year Leiden experience.
Sont JK; van Stiphout WA; Noordijk EM; Molenaar J; Zwetsloot-Schonk JH; Willemze R; Vandenbroucke JP
Ann Hematol; 1992 Nov; 65(5):213-8. PubMed ID: 1457578
[TBL] [Abstract][Full Text] [Related]
33. Leukaemia complicating treatment for Hodgkin's disease: the experience of the British National Lymphoma Investigation.
Devereux S; Selassie TG; Vaughan Hudson G; Vaughan Hudson B; Linch DC
BMJ; 1990 Nov; 301(6760):1077-80. PubMed ID: 2249071
[TBL] [Abstract][Full Text] [Related]
34. Risk of second malignancy after non-Hodgkin's lymphoma: a British Cohort Study.
Mudie NY; Swerdlow AJ; Higgins CD; Smith P; Qiao Z; Hancock BW; Hoskin PJ; Linch DC
J Clin Oncol; 2006 Apr; 24(10):1568-74. PubMed ID: 16520465
[TBL] [Abstract][Full Text] [Related]
35. Subsequent malignancies in children and adolescents after treatment for Hodgkin's disease.
Beaty O; Hudson MM; Greenwald C; Luo X; Fang L; Wilimas JA; Thompson EI; Kun LE; Pratt CB
J Clin Oncol; 1995 Mar; 13(3):603-9. PubMed ID: 7884422
[TBL] [Abstract][Full Text] [Related]
36. Effects of radiochemotherapy and splenectomy on cellular immunity in long-term survivors of Hodgkin's disease and non-Hodgkin's lymphoma.
Steele R; Han T
Cancer; 1978 Jul; 42(1):133-9. PubMed ID: 667791
[TBL] [Abstract][Full Text] [Related]
37. Long-term risk of second malignancy in survivors of Hodgkin's disease treated during adolescence or young adulthood.
van Leeuwen FE; Klokman WJ; Veer MB; Hagenbeek A; Krol AD; Vetter UA; Schaapveld M; van Heerde P; Burgers JM; Somers R; Aleman BM
J Clin Oncol; 2000 Feb; 18(3):487-97. PubMed ID: 10653864
[TBL] [Abstract][Full Text] [Related]
38. High risk of breast carcinoma after irradiation of young women with Hodgkin's disease.
Aisenberg AC; Finkelstein DM; Doppke KP; Koerner FC; Boivin JF; Willett CG
Cancer; 1997 Mar; 79(6):1203-10. PubMed ID: 9070499
[TBL] [Abstract][Full Text] [Related]
39. Analysis of the risk of solid tumor following Hodgkin's disease.
Maurizi Enrici R; Anselmo AP; Osti MF; Santoro M; Tombolini V; Mandelli F; Biagini C
Haematologica; 1997; 82(1):57-63. PubMed ID: 9107084
[TBL] [Abstract][Full Text] [Related]
40. Gastrointestinal cancer after treatment of Hodgkin's disease.
Birdwell SH; Hancock SL; Varghese A; Cox RS; Hoppe RT
Int J Radiat Oncol Biol Phys; 1997 Jan; 37(1):67-73. PubMed ID: 9054878
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]